51 results
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
to design highly specific, safe therapeutics for a wide variety of disease targets less addressable by small molecules. Absci was founded on a technology … their corresponding antigens, offering new therapeutic targets, as well as the cognate binding partners, for further potential validation and optimization. AI
424B5
ABSI
Absci Corp
28 Feb 24
Prospectus supplement for primary offering
8:34am
pipeline: We aim to create therapeutic assets comprising our own internal program pipeline. With the ability to find targets and develop potential best … novel drug targets, discover optimal biotherapeutic candidates, and generate the cell lines to manufacture them in a single efficient process. We believe
8-K
29t94xy6 ei
27 Feb 24
Results of Operations and Financial Condition
4:45pm
424B5
efsx bl9px
27 Feb 24
Prospectus supplement for primary offering
4:40pm
8-K
EX-99.1
fipvzm
8 Jan 24
Absci Corporation 2024 All Rights Reserved 42ND JP Morgan Healthcare Conference
7:08am
8-K
EX-99.1
quwkjh7 pqiuj
20 Dec 23
Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline
8:30am
8-K
EX-99.1
mneqpooa9l
4 Dec 23
Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
7:31am
8-K
EX-99.1
06y cn5xzht3
14 Nov 23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
4:40pm
8-K
EX-99.2
klpt04kwo356og
14 Nov 23
Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results
4:40pm
8-K
EX-99.1
yas9wyxk9wq5msnf a6
14 Aug 23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
8:13am
424B5
epfxpchkdbgad57s
16 Jun 23
Prospectus supplement for primary offering
4:45pm
8-K
EX-99.1
y525ogcc92k7pkii77x
15 May 23
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
4:08pm
ARS
sjugtzt bg0vvsyw
28 Apr 23
Annual report to shareholders
12:00am